Failure to Launch
The importance of inflammation and inflammatory pathways in atherosclerotic disease and acute coronary syndromes (ACS) is well established. The success of statin therapy rests not only on potently reducing levels of low-density lipoprotein cholesterol, but also on the many beneficial, pleiotropic ef...
Main Authors: | Jennifer A. Rymer, MD, MBA, L. Kristin Newby, MD, MHS |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-08-01
|
Series: | JACC: Basic to Translational Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452302X17301468 |
Similar Items
-
Effect of lornoxicam on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome
by: Nikita Valer'evich Lomakin, et al.
Published: (2010-12-01) -
It Happened While You Were Sleeping
by: L. Kristin Newby
Published: (2016-06-01) -
Association between Non-Steroidal Anti-Inflammatory Drug Use and Major Cardiovascular Outcomes in Patients with Acute Coronary Syndrome in the Arabian Gulf
by: Ibrahim Al-Zakwani, et al.
Published: (2023-08-01) -
High-dose bolus tirofiban versus low-dose bolus in patients with acute coronary syndrome undergoing percutaneous coronary intervention
by: Taner Ulus, et al.
Published: (2017-03-01) -
Recognition of Recurrent Stent Failure Due to Calcified Nodule
by: Jeffrey W. Moses, MD, et al.
Published: (2020-10-01)